Abstract:Purpose of review: The goal of this manuscript is to summarize the current understanding of the secreted APOA1 binding protein (AIBP), encoded by NAXE, in angiogenesis, hematopoiesis, and inflammation. The studies on AIBP illustrate a critical connection between lipid metabolism and the aforementioned endothelial and immune cell biology. Recent findings: AIBP dictates both developmental processes such as angiogenesis and hematopoiesis, and pathological events such as inflammation, tumorigenesis, and atherosclerosis. Although cholesterol efflux dictates AIBP-mediated lipid raft disruption in many of the cell types, recent studies document cholesterol efflux-independent mechanism involving Cdc42-mediated cytoskeleton remodeling in macrophages. AIBP disrupts lipid rafts and impairs raft-associated VEGFR2 but facilitates non-raft-associated NOTCH1 signaling. Furthermore, AIBP can induce cholesterol biosynthesis gene SREBP2 activation, which in turn transactivates NOTCH1 and supports specification of hematopoietic stem and progenitor cells (HSPCs). In addition, AIBP also binds TLR4 and represses TLR4-mediated inflammation. In this review, we summarize the latest research on AIBP, focusing on its role in cholesterol metabolism and the attendant effects on lipid raft-regulated VEGFR2 and non-raft-associated NOTCH1 activation in angiogenesis, SREBP2-upregulated NOTCH1 signaling in hematopoiesis, and TLR4 signaling in inflammation and atherogenesis. We will discuss its potential therapeutic applications in angiogenesis and inflammation due to selective targeting of activated cells.

Recent Progress in Research of Adipocyte Fatty Acid Binding Protein and Atherosclerosis

Effect of adiponectin on obesity-linked diseases

The Biological Functions and Regulatory Mechanisms of Fatty Acid Binding Protein 5 in Various Diseases

Fatty Acid Binding Protein 4 Expression Marks a Population of Adipocyte Progenitors in White and Brown Adipose Tissues

Small molecule inhibitors of human adipocyte fatty acid binding protein (FABP4).

Fatty Acid-Binding Protein 4 in Cardiovascular and Metabolic Diseases

Progress in Adiponectin

Binding Difference of Inhibitors ACD and TDZ to A-FABP Revealed by Molecular Dynamics Simulations

Electrostatic interaction-mediated conformational changes of adipocyte fatty acid binding protein probed by molecular dynamics simulation

Mechanism and Clinical Evidence of Lipocalin‐2 and Adipocyte Fatty Acid‐binding Protein Linking Obesity and Atherosclerosis

Advancement in structure and function of fatty acid-binding proteins

Circulating adipocyte fatty acid-binding protein levels are independently associated with heart failure.

Analysis of binding affinity and docking of novel fatty acid-binding protein (FABP) ligands

Multifaced Roles in Reproduction, Pregnancy, and Offspring Health

Recent Advances on Adiponectin Receptor

Serum Levels Of Adipocyte Fatty Acid-Binding Protein Are Associated With The Severity Of Coronary Artery Disease In Chinese Women

Novel fatty acid binding protein 4 (FABP4) inhibitors: virtual screening, synthesis and crystal structure determination.

[Research progress in regulation of adiponectin receptors expression].

AIBP, Angiogenesis, Hematopoiesis, and Atherogenesis

Adipocyte Fatty Acid Binding Protein Promotes the Onset and Progression of Liver Fibrosis via Mediating the Crosstalk between Liver Sinusoidal Endothelial Cells and Hepatic Stellate Cells

Protective Roles of Adiponectin in Obesity-Related Fatty Liver Diseases: Mechanisms and Therapeutic Implications